| XFIV | BondBloxx Bloomberg FiveYrTrgDurUSTrsETF | 11.49% |
| SPYM | State Street® SPDR® Port S&P 500® ETF | 8.80% |
| XHLF | BondBloxx Bloomberg SixMthTrgDurUSTrsETF | 4.54% |
| LLY | Eli Lilly and Co | 4.34% |
| UNH | UnitedHealth Group Inc | 3.76% |
| JNJ | Johnson & Johnson | 2.66% |
| TMO | Thermo Fisher Scientific Inc | 2.62% |
| ABT | Abbott Laboratories | 2.18% |
MHIP aims to preserve and enhancepurchasingpower amid rising medical costs through proprietary actuarial data and quantitative modeling. The fundanalysis relies on Mis extensive dataset of real healthcare claims, covering approximately 35 million insured individuals, to project healthcare inflation based on trends in medical and pharmacy costs.Investments consist ofequities and fixed income securities across the healthcare supply chain, along with inflation-hedging instruments such as commodities, TIPS, and Treasury bonds.Typically, MHIP isrebalanced monthly using a quantitative model toreflect changes in US healthcare cost inflation. The strategy increases exposure to equities and commodities during periods of higher inflation and shifts towarddebtwhen inflation is lower.Holdings may also include derivatives such as swaps, options, and futures, as well as ETFs.
Milliman Healthcare Inflation Plus ETF
No recent news for MHIP. The ingest cron pulls every 15 minutes during market hours.